相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis
Laura J. O'Byrne et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)
Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease
Uma Mahadevan et al.
GASTROENTEROLOGY (2021)
Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss
Siobhan Quenby et al.
LANCET (2021)
Perceptions of Pregnancy and Lactation from the Pregnancy and Lactation Autoimmune Network Registry
Brooke S. Mills et al.
JOURNAL OF RHEUMATOLOGY (2020)
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
Victoria Furer et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases
Jaume Alijotas-Reig et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy
A. Coomarasamy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A randomized controlled trial of etanercept in the treatment of refractory recurrent spontaneous abortion with innate immune disorders
Jinhua Fu et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2019)
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group
Uma Mahadevan et al.
GASTROENTEROLOGY (2019)
Pregnancy Outcomes After Exposure to Certolizumab Pegol Updated Results From a Pharmacovigilance Safety Database
Megan E. B. Clowse et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Global epidemiology of use of and disparities in caesarean sections
Ties Boerma et al.
LANCET (2018)
Gestational hormone trajectories and early pregnancy failure: a reassessment
Paul G. Whittaker et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2018)
ESHRE guideline: recurrent pregnancy loss
Ruth Bender Atik et al.
HUMAN REPRODUCTION OPEN (2018)
Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study
Xavier Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease
C. H. Seow et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Association between Serum TNF-α Levels and Recurrent Spontaneous Miscarriage: A Meta-analysis
Chengdong Zhang et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2016)
Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis
Rekha N. Pillai et al.
HUMAN REPRODUCTION UPDATE (2016)
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
Carina Gotestam Skorpen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Differences in Serum Human Chorionic Gonadotropin Rise in Early Pregnancy by Race and Value at Presentation
Kurt T. Barnhart et al.
OBSTETRICS AND GYNECOLOGY (2016)
BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids
Julia Flint et al.
RHEUMATOLOGY (2016)
Recurrent Pregnancy Loss Evaluation and Treatment
Lora Shahine et al.
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2015)
Proceedings From the American College of Rheumatology Reproductive Health Summit: The Management of Fertility, Pregnancy, and Lactation in Women With Autoimmune and Systemic Inflammatory Diseases
Arthur Kavanaugh et al.
ARTHRITIS CARE & RESEARCH (2015)
The ESHRE/ESGE consensus on the classification of female genital tract congenital anomalies,
Grigoris F. Grimbizis et al.
HUMAN REPRODUCTION (2013)
Fetomaternal immune cross-talk and its consequences for maternal and offspring's health
Petra C. Arck et al.
NATURE MEDICINE (2013)
Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion
Edward E. Winger et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2008)
Tumor necrosis factor-α inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures
S Bauer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Symptomatic patients with an early viable intrauterine pregnancy: hCG curves redefined
KT Barnhart et al.
OBSTETRICS AND GYNECOLOGY (2004)
Microvascular permeability is related to circulating levels of tumour necrosis factor-α in pre-eclampsia
N Anim-Nyame et al.
CARDIOVASCULAR RESEARCH (2003)
Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy
SC Ng et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2002)